Evaluation of the safety, tolerability and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
129
Phosphate buffered saline placebo for injection
Investigational Site
Birmingham, Alabama, United States
Investigational Site
Beverly Hills, California, United States
Investigational Site
Beverly Hills, California, United States
Change From Baseline in Clinician-Reported Submental Fat Rating Scale Scores
The CR-SMFRS score is based on the investigator's clinical evaluation of the participant, where submental fullness is scored on a 5-point ordinal scale (0-4) with 0 = absent, 1 = mild, 2 = moderate, 3 = severe, and 4 = extreme. A negative change from Baseline indicates improvement.
Time frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
Change From Baseline in Patient-Reported Submental Fat Scale Rating Scale (PR-SMFRS)
The PR-SMFRS is based on the participant's response to the question "How much fat do you have under your chin right now?" answered on a 5-point ordinal scale (0-4) with 0 = no chin fat at all, 1 = a slight amount of chin fat, 2 = a moderate amount of chin fat, 3 = a large amount of chin fat, and 4 = a very large amount of chin fat. A negative change from Baseline indicates improvement.
Time frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
Change From Baseline in Patient-Reported Submental Fat Impact Scale (PR-SMFIS)
The PR-SMFIS assesses the impact of submental fat on self-perception of 6 emotional and visual characteristics related to the appearance of submental fullness (unhappy, bothered, self-conscious, embarrassed, look older, and look overweight) as evaluated by the participant. Each item is rated on an 11-point numeric scale from 0 to 10. Scores for the 6 items were averaged to generate a PR-SMFIS total scale score ranging from 0 to 10 where 0 is a positive outcome and 10 is a negative outcome. A negative change from Baseline indicates improvement.
Time frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
Change From Baseline in Submental Fat Volume
Submental fat volume was measured by magnetic resonance imaging (MRI).
Time frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Investigational Site
San Francisco, California, United States
Investigational Site
Naperville, Illinois, United States
Investigational Site
Chestnut Hill, Massachusetts, United States
Investigational Site
Fridley, Minnesota, United States
Investigational Site
St Louis, Missouri, United States
Investigational Site
Omaha, Nebraska, United States
Investigational Site
Plano, Texas, United States
Change From Baseline in Submental Fat Thickness
Submental fat thickness was measured by magnetic resonance imaging (MRI).
Time frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)